Literature DB >> 2524876

V beta-specific stimulation of human T cells by staphylococcal toxins.

J Kappler1, B Kotzin, L Herron, E W Gelfand, R D Bigler, A Boylston, S Carrel, D N Posnett, Y Choi, P Marrack.   

Abstract

The staphylococcal toxins are responsible for a number of diseases in man and other animals. Many of them have also long been known to be powerful T cell stimulants. They do not, however, stimulate all T cells. On the contrary, each toxin reacts with human T cells bearing particular V beta sequences as part of their receptors for major histocompatibility complex protein-associated antigen. The specificity of these toxins for V beta s puts them in the recently described class of superantigens and may account for the differential sensitivity of different individuals to the toxic effects of these proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524876     DOI: 10.1126/science.2524876

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  214 in total

1.  Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens.

Authors:  L R Plano; D M Gutman; M Woischnik; C M Collins
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.

Authors:  J B Travers; Q A Hamid; D A Norris; C Kuhn; R C Giorno; P M Schlievert; E R Farmer; D Y Leung
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

3.  Role of endogenous interleukin-12 in immune response to staphylococcal enterotoxin B in mice.

Authors:  F N Lauw; S Florquin; P Speelman; S J van Deventer; T van der Poll
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha.

Authors:  Heike I Krupka; Brent W Segelke; Robert G Ulrich; Sabine Ringhofer; Mark Knapp; Bernhard Rupp
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

5.  Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responses.

Authors:  M J Litton; M Dohlsten; J Hansson; A Rosendahl; L Ohlsson; T Kalland; J Andersson; U Andersson
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

6.  Feedback suppression of staphylococcal enterotoxin-stimulated T-lymphocyte proliferation by macrophages through inductive nitric oxide synthesis.

Authors:  K Isobe; I Nakashima
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 7.  Superantigens: biology, immunology, and potential role in disease.

Authors:  C G Drake; B L Kotzin
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

8.  Immunological study on CD3 defective cutaneous T cell lymphoma cells from a patient with Sézary syndrome.

Authors:  S Sano; Y Matsui; S Itami; K Yoshikawa
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

9.  Differential use of immunoglobulin light chain genes and B lymphocyte expansion at sites of disease in rheumatoid arthritis (RA) compared with circulating B lymphocytes.

Authors:  S P Moyes; R N Maini; R A Mageed
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

10.  Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).

Authors:  M Nielsen; A Svejgaard; C Röpke; M Nordahl; N Odum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.